Keywords: Tumors (Pre-Treatment), Machine Learning/Artificial Intelligence
Motivation: A novel and noninvasive method for distinguishing intracranial solitary fibrous tumor (ISFT) from angiomatous meningioma (AM) and predicting patient outcomes is urgent.
Goal(s): To evaluate the value of a MRI-based deep learning radiomic nomogram (DLRN) in distinguishing ISFT from AM and predicting patient outcomes.
Approach: A MRI-based DLRN was developed on training cohort (TC). We then validated it's performance on external validation cohort (EVC). Moreover, we investigated the value of the DLRN in survival analysis.
Results: The performance of DLRN was excellent (0.86 [0.84–0.88]) on EVC. Besides, DLRN was significantly associated with the overall survival (OS) of patients (n=273).
Impact: The proposed DLRN can potentially provide a noninvasive method for neurosurgeon to offer decision support for developing personalized treatment plans and predicting patient outcomes.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords